Dr Jennifer Ong

BPharm(Hons), PhD, GradCertEdStudies
Lecturer

A15 - Pharmacy And Bank Building
The University of Sydney

Telephone +61 2 8627 0234

Biographical details

Jennifer is a lecturer and clinical placements coordinator at the Sydney Pharmacy School. She completed her PhD in the area of drug discovery and formulation (Thesis title: Structure-based drug discovery of small molecule modulators of the protein-protein interaction between EGFR and PTP1B) and has extensive experience with in silico molecular modelling as well as in vitro compound testing. She continues to practise as a registered pharmacist and is interested in identifying effective teaching strategies for delivery of optimal work-integrated learning experiences to Pharmacy students. Other research interests include analysis of clinical data for the development of practice guidelines and quality improvement purposes. Jennifer continues to maintain interest in the area of drug discovery as an office bearer in the Association of Molecular Modelling Australasia (AMMA).

Research interests

Work-integrated learning, clinical practice, drug discovery

Teaching and supervision

Jennifer is primarily involved the design and delivery of work-integrated learning to undergraduate and postgraduate students as part of the Pharmacy Placement Program.

She has also supervised research projects undertaken by postgraduate students, Honours students and Vacation Scholars.

Current projects

  • Pharmacy education. Evaluating the impact of an integrated curriculum on student academic performance and learning experience
  • Clinical practice. Investigating the management of antithrombotic therapy during the perioperative period and incidence of stroke at an Australian hospital

Associations

AHPRA, PSA, AMMA

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Ong, J., Groundwater, P., Hibbs, D. (2015). Phytotherapy Pharmacophores for Major Cellular Drug Targets. In Iqbal Ramzan (Eds.), Phytotherapies: Efficacy, Safety, and Regulation, (pp. 268-311). New Jersey: Wiley. [More Information]

Journals

  • Du, J., Stanton, S., Williams, P., Ong, J., Groundwater, P., Overgaard, J., Platts, J., Hibbs, D. (2018). Using electron density to predict synthon formation in a 4-hydroxybenzoic acid: 4,4'-bipyridine co-crystal. Crystal Growth and Design, 18(3), 1786-1798. [More Information]
  • Wilkinson, S., Barron, M., O'Brien-Brown, J., Janssen, B., Stokes, L., Werry, E., Chishty, M., Skarratt, K., Ong, J., Hibbs, D., Fuller, S., Kassiou, M., et al (2017). Pharmacological evaluation of novel bioisosteres of an adamantanyl benzamide P2X7 receptor antagonist. ACS Chemical Neuroscience, 8(11), 2374-2380. [More Information]
  • Reekie, T., Wilkinson, S., Law, V., Hibbs, D., Ong, J., Kassiou, M. (2017). Rapid access to N-(indol-2-yl)amides and N-(indol-3-yl)amides as unexplored pharmacophores. Organic and Biomolecular Chemistry, 15(3), 576-580. [More Information]
  • Gao, Q., Hanh, J., Varadi, L., Cairns, R., Sjoestroem, H., Liao, V., Wood, P., Balaban, S., Ong, J., Lin, H., Lai, F., Hoy, A., Grewal, T., Groundwater, P., Hibbs, D. (2015). Identification of dual PPARα/γ agonists and their effects on lipid metabolism. Bioorganic and Medicinal Chemistry, 23(24), 7676-7684. [More Information]
  • Merlot, A., Sahni, S., Lane, D., Fordham, A., Pantarat, N., Hibbs, D., Richardson, V., Doddareddy, M., Ong, J., Huang, M., Richardson, D., Kalinowski, D. (2015). Potentiating the cellular targeting and anti-tumor activity of Dp44mT via binding to human serum albumin: two saturable mechanisms of Dp44mT uptake by cells. Oncotarget, 6(12), 10374-10398. [More Information]
  • Austin, C., Kahlert, J., Issa, F., Reed, J., Smith, J., Ioppolo, J., Ong, J., Jamie, J., Hibbs, D., Rendina, L. (2014). The first indoleamine-2,3-dioxygenase-1 (IDO1) inhibitors containing carborane. Dalton Transactions, 43(28), 10719-10724. [More Information]
  • Gu, R., Hibbs, D., Ong, J., Edwards, R., Murray, M. (2014). The multikinase inhibitor axitinib is a potent inhibitor of human CYP1A2. Biochemical Pharmacology, 88(2), 245-252. [More Information]

2018

  • Du, J., Stanton, S., Williams, P., Ong, J., Groundwater, P., Overgaard, J., Platts, J., Hibbs, D. (2018). Using electron density to predict synthon formation in a 4-hydroxybenzoic acid: 4,4'-bipyridine co-crystal. Crystal Growth and Design, 18(3), 1786-1798. [More Information]

2017

  • Wilkinson, S., Barron, M., O'Brien-Brown, J., Janssen, B., Stokes, L., Werry, E., Chishty, M., Skarratt, K., Ong, J., Hibbs, D., Fuller, S., Kassiou, M., et al (2017). Pharmacological evaluation of novel bioisosteres of an adamantanyl benzamide P2X7 receptor antagonist. ACS Chemical Neuroscience, 8(11), 2374-2380. [More Information]
  • Reekie, T., Wilkinson, S., Law, V., Hibbs, D., Ong, J., Kassiou, M. (2017). Rapid access to N-(indol-2-yl)amides and N-(indol-3-yl)amides as unexplored pharmacophores. Organic and Biomolecular Chemistry, 15(3), 576-580. [More Information]

2015

  • Gao, Q., Hanh, J., Varadi, L., Cairns, R., Sjoestroem, H., Liao, V., Wood, P., Balaban, S., Ong, J., Lin, H., Lai, F., Hoy, A., Grewal, T., Groundwater, P., Hibbs, D. (2015). Identification of dual PPARα/γ agonists and their effects on lipid metabolism. Bioorganic and Medicinal Chemistry, 23(24), 7676-7684. [More Information]
  • Ong, J., Groundwater, P., Hibbs, D. (2015). Phytotherapy Pharmacophores for Major Cellular Drug Targets. In Iqbal Ramzan (Eds.), Phytotherapies: Efficacy, Safety, and Regulation, (pp. 268-311). New Jersey: Wiley. [More Information]
  • Merlot, A., Sahni, S., Lane, D., Fordham, A., Pantarat, N., Hibbs, D., Richardson, V., Doddareddy, M., Ong, J., Huang, M., Richardson, D., Kalinowski, D. (2015). Potentiating the cellular targeting and anti-tumor activity of Dp44mT via binding to human serum albumin: two saturable mechanisms of Dp44mT uptake by cells. Oncotarget, 6(12), 10374-10398. [More Information]

2014

  • Austin, C., Kahlert, J., Issa, F., Reed, J., Smith, J., Ioppolo, J., Ong, J., Jamie, J., Hibbs, D., Rendina, L. (2014). The first indoleamine-2,3-dioxygenase-1 (IDO1) inhibitors containing carborane. Dalton Transactions, 43(28), 10719-10724. [More Information]
  • Gu, R., Hibbs, D., Ong, J., Edwards, R., Murray, M. (2014). The multikinase inhibitor axitinib is a potent inhibitor of human CYP1A2. Biochemical Pharmacology, 88(2), 245-252. [More Information]

For support on your academic profile contact .